{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T05:00:52Z","timestamp":1784869252554,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Radiol"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>This study aimed to evaluate whether adding diffusion-weighted imaging (DWI) to dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) improves the differentiation between nonmalignant and malignant MRI-detected lesions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>\n                      A total of 36 patients with 40 Breast Imaging-Reporting and Data System (BI-RADS) category 4 MRI-detected lesions were analyzed. Two readers independently evaluated lesion visibility on two\n                      <jats:italic>b<\/jats:italic>\n                      -value DWIs (\n                      <jats:italic>b<\/jats:italic>\n                      \u2009=\u2009800\u00a0s\/mm\n                      <jats:sup>2<\/jats:sup>\n                      , DWI\n                      <jats:sub>800<\/jats:sub>\n                      and\n                      <jats:italic>b<\/jats:italic>\n                      \u2009=\u20091500\u00a0s\/mm\n                      <jats:sup>2<\/jats:sup>\n                      , DWI\n                      <jats:sub>1500<\/jats:sub>\n                      ) using a five-point scale (from 0\u2009=\u2009poor to 4\u2009=\u2009excellent) and measured the apparent diffusion coefficient (ADC) values. DWI visibility scores and ADC values were compared between nonmalignant and malignant lesions. For the diagnostic performance analysis, lesions were classified as DWI-positive (scores 2\u20134, suggestive of malignancy) or DWI-negative (scores 0\u20131, suggestive of benignity).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The inter-observer agreement of the DWI visibility score was substantial for both DWI\n                      <jats:sub>800<\/jats:sub>\n                      (\u03ba\u2009=\u20090.923) and DWI\n                      <jats:sub>1500<\/jats:sub>\n                      (\u03ba\u2009=\u20090.864). The lesion visibility score was higher on DWI\n                      <jats:sub>1500<\/jats:sub>\n                      than on DWI\n                      <jats:sub>800<\/jats:sub>\n                      . The score was significantly higher for malignant than for nonmalignant MRI-detected lesions on both DWI\n                      <jats:sub>800<\/jats:sub>\n                      (reader 1: 2.74 vs. 1.57, p\u2009=\u20090.012; reader 2: 2.95 vs. 1.81, p\u2009=\u20090.020) and DWI\n                      <jats:sub>1500<\/jats:sub>\n                      (reader 1: 3.11 vs 2.24, p\u2009=\u20090.048; reader 2: 3.00 vs. 1.95, p\u2009=\u20090.038). For mass lesions, both DWI\n                      <jats:sub>800<\/jats:sub>\n                      and DWI\n                      <jats:sub>1500<\/jats:sub>\n                      achieved 100% sensitivity and a negative predictive value for both readers, whereas all DWI-negative malignant lesions demonstrated non-mass enhancement. Overall, the mean and minimum ADC values did not differ significantly between nonmalignant and malignant lesions.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The present findings suggest that DWI visibility provides additional value for distinguishing between nonmalignant and malignant BI-RADS category 4 MRI-detected breast lesions. Particularly for mass lesions, DWI-negative MRI-detected lesions were associated with nonmalignant pathology, indicating a potential role for DWI in reducing unnecessary biopsies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11604-026-01981-z","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T07:04:07Z","timestamp":1775804647000},"page":"1382-1393","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Additional diagnostic value of lesion visibility on diffusion-weighted imaging for differentiating BI-RADS category 4 MRI-detected breast lesions"],"prefix":"10.1007","volume":"44","author":[{"given":"Saeko","family":"Usui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4161-3201","authenticated-orcid":false,"given":"Mariko","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Onishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,10]]},"reference":[{"issue":"1","key":"1981_CR1","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.23.29933","volume":"222","author":"RL Gullo","year":"2024","unstructured":"Gullo RL, Partridge SC, Shin HJ, Thakur SB, Pinker K. Update on DWI for breast cancer diagnosis and treatment monitoring. AJR Am J Roentgenol. 2024;222(1):e2329933. https:\/\/doi.org\/10.2214\/AJR.23.29933.","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"1981_CR2","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s12282-023-01521-x","volume":"31","author":"K Kubota","year":"2024","unstructured":"Kubota K, Nakashima K, Kataoka M, Inoue K, Goto M, Kanbayashi C, et al. The Japanese breast cancer society clinical practice guidelines for breast cancer screening and diagnosis, 2022 edition. Breast Cancer. 2024;31(2):157\u201364. https:\/\/doi.org\/10.1007\/s12282-023-01521-x.","journal-title":"Breast Cancer"},{"issue":"5","key":"1981_CR3","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1007\/s00330-019-06620-y","volume":"30","author":"SE Lee","year":"2020","unstructured":"Lee SE, Lee JH, Han K, Kim EK, Kim MJ, Moon HJ, et al. BI-RADS category 3, 4, and 5 lesions identified at preoperative breast MRI in patients with breast cancer: implications for management. Eur Radiol. 2020;30(5):2773\u201381. https:\/\/doi.org\/10.1007\/s00330-019-06620-y.","journal-title":"Eur Radiol"},{"issue":"6","key":"1981_CR4","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.2214\/AJR.12.8953","volume":"201","author":"K Yamaguchi","year":"2013","unstructured":"Yamaguchi K, Schacht D, Sennett CA, Newstead GM, Imaizumi T, Irie H, et al. Decision making for breast lesions initially detected at contrast-enhanced breast MRI. AJR Am J Roentgenol. 2013;201(6):1376\u201385. https:\/\/doi.org\/10.2214\/AJR.12.8953.","journal-title":"AJR Am J Roentgenol"},{"issue":"12","key":"1981_CR5","doi-asserted-by":"publisher","first-page":"4361","DOI":"10.1007\/s00330-016-4326-2","volume":"26","author":"O Arponen","year":"2016","unstructured":"Arponen O, Masarwah A, Sutela A, Taina M, K\u00f6n\u00f6nen M, Sironen R, et al. Incidentally detected enhancing lesions found in breast MRI: analysis of apparent diffusion coefficient and T2 signal intensity significantly improves specificity. Eur Radiol. 2016;26(12):4361\u201370. https:\/\/doi.org\/10.1007\/s00330-016-4326-2.","journal-title":"Eur Radiol"},{"issue":"7","key":"1981_CR6","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1158\/1078-0432.CCR-20-3037","volume":"27","author":"P Clauser","year":"2021","unstructured":"Clauser P, Krug B, Bickel H, Dietzel M, Pinker K, Neuhaus VF, et al. Diffusion-weighted imaging allows for downgrading MR BI-RADS 4 lesions in contrast-enhanced MRI of the breast to avoid unnecessary biopsy. Clin Cancer Res. 2021;27(7):1941\u20138. https:\/\/doi.org\/10.1158\/1078-0432.CCR-20-3037.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"1981_CR7","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1158\/1078-0432.CCR-18-2967","volume":"25","author":"H Rahbar","year":"2019","unstructured":"Rahbar H, Zhang Z, Chenevert TL, Romanoff J, Kitsch AE, Hanna LG, et al. Utility of diffusion-weighted imaging to decrease unnecessary biopsies prompted by breast MRI: a trial of the ECOG-ACRIN cancer research group (A6702). Clin Cancer Res. 2019;25(6):1756\u201365. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-2967.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"1981_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-6201-4","volume":"19","author":"A Surov","year":"2019","unstructured":"Surov A, Meyer HJ, Wienke A. Can apparent diffusion coefficient (ADC) distinguish breast cancer from benign breast findings? A meta-analysis based on 13 847 lesions. BMC Cancer. 2019;19(1):955. https:\/\/doi.org\/10.1186\/s12885-019-6201-4.","journal-title":"BMC Cancer"},{"issue":"6","key":"1981_CR9","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1177\/0284185115597265","volume":"57","author":"L Zhang","year":"2016","unstructured":"Zhang L, Tang M, Min Z, Lu J, Lei X, Zhang X. Accuracy of combined dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging for breast cancer detection: a meta-analysis. Acta Radiol. 2016;57(6):651\u201360. https:\/\/doi.org\/10.1177\/0284185115597265.","journal-title":"Acta Radiol"},{"issue":"3","key":"1981_CR10","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.diii.2017.01.001","volume":"98","author":"DA Spak","year":"2017","unstructured":"Spak DA, Plaxco JS, Santiago L, Dryden MJ, Dogan BE. BI-RADS\u00ae fifth edition: a summary of changes. Diagn Interv Imaging. 2017;98(3):179\u201390.","journal-title":"Diagn Interv Imaging"},{"issue":"6","key":"1981_CR11","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1002\/jmri.26809","volume":"50","author":"H Bickel","year":"2019","unstructured":"Bickel H, Polanec SH, Wengert G, Pinker K, Bogner W, Helbich TH, et al. Diffusion-weighted MRI of breast cancer: improved lesion visibility and image quality using synthetic b-values. J Magn Reson Imaging. 2019;50(6):1754\u201361. https:\/\/doi.org\/10.1002\/jmri.26809.","journal-title":"J Magn Reson Imaging"},{"issue":"2","key":"1981_CR12","doi-asserted-by":"publisher","first-page":"218","DOI":"10.4048\/jbc.2021.24.e19","volume":"24","author":"HJ Shin","year":"2021","unstructured":"Shin HJ, Lee SH, Park VY, Yoon JH, Kang BJ, Yun B, et al. Diffusion-weighted magnetic resonance imaging for breast cancer screening in high-risk women: design and imaging protocol of a prospective multicenter study in Korea. J Breast Cancer. 2021;24(2):218\u201328. https:\/\/doi.org\/10.4048\/jbc.2021.24.e19.","journal-title":"J Breast Cancer"},{"issue":"8","key":"1981_CR13","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/j.acra.2020.03.011","volume":"28","author":"MR DelPriore","year":"2021","unstructured":"DelPriore MR, Biswas D, Hippe DS, Zecevic M, Parsian S, Scheel JR, et al. Breast cancer conspicuity on computed versus acquired high b-value diffusion-weighted MRI. Acad Radiol. 2021;28(8):1108\u201317. https:\/\/doi.org\/10.1016\/j.acra.2020.03.011.","journal-title":"Acad Radiol"},{"issue":"3","key":"1981_CR14","doi-asserted-by":"publisher","first-page":"229","DOI":"10.2463\/mrms.2012-0028","volume":"12","author":"R Woodhams","year":"2013","unstructured":"Woodhams R, Inoue Y, Ramadan S, Hata H, Ozaki M. Diffusion-weighted imaging of the breast: comparison of b-values 1000 s\/mm2 and 1500 s\/mm2. Magn Reson Med Sci. 2013;12(3):229\u201334.","journal-title":"Magn Reson Med Sci"},{"issue":"5","key":"1981_CR15","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1007\/s00330-009-1654-5","volume":"20","author":"PA Baltzer","year":"2010","unstructured":"Baltzer PA, Benndorf M, Dietzel M, Gajda M, Camara O, Kaiser WA. Sensitivity and specificity of unenhanced MR mammography (DWI combined with T2-weighted TSE imaging, ueMRM) for the differentiation of mass lesions. Eur Radiol. 2010;20(5):1101\u201310. https:\/\/doi.org\/10.1007\/s00330-009-1654-5.","journal-title":"Eur Radiol"},{"key":"1981_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2022.110523","volume":"156","author":"MA Marino","year":"2022","unstructured":"Marino MA, Avendano D, Sevilimedu V, Thakur S, Martinez D, Lo Gullo R, et al. Limited value of multiparametric MRI with dynamic contrast-enhanced and diffusion-weighted imaging in non-mass enhancing breast tumors. Eur J Radiol. 2022;156:110523. https:\/\/doi.org\/10.1016\/j.ejrad.2022.110523.","journal-title":"Eur J Radiol"},{"issue":"1","key":"1981_CR17","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1007\/s00330-020-07094-z","volume":"31","author":"I Daimiel Naranjo","year":"2021","unstructured":"Daimiel Naranjo I, Lo Gullo R, Saccarelli C, Thakur SB, Bitencourt A, Morris EA, et al. Diagnostic value of diffusion-weighted imaging with synthetic b-values in breast tumors: comparison with dynamic contrast-enhanced and multiparametric MRI. Eur Radiol. 2021;31(1):356\u201367. https:\/\/doi.org\/10.1007\/s00330-020-07094-z.","journal-title":"Eur Radiol"},{"issue":"1","key":"1981_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-019-1208-y","volume":"21","author":"D Avendano","year":"2019","unstructured":"Avendano D, Marino MA, Leithner D, Thakur S, Bernard-Davila B, Martinez DF, et al. Limited role of DWI with apparent diffusion coefficient mapping in breast lesions presenting as non-mass enhancement on dynamic contrast-enhanced MRI. Breast Cancer Res. 2019;21(1):136. https:\/\/doi.org\/10.1186\/s13058-019-1208-y.","journal-title":"Breast Cancer Res"},{"issue":"1","key":"1981_CR19","doi-asserted-by":"publisher","first-page":"95","DOI":"10.21037\/qims-21-355","volume":"12","author":"S Jeong","year":"2022","unstructured":"Jeong S, Kim TH. Diffusion-weighted imaging of breast invasive lobular carcinoma: comparison with invasive carcinoma of no special type using a histogram analysis. Quant Imaging Med Surg. 2022;12(1):95\u2013105. https:\/\/doi.org\/10.21037\/qims-21-355.","journal-title":"Quant Imaging Med Surg"},{"issue":"3","key":"1981_CR20","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1007\/s00330-019-06510-3","volume":"30","author":"P Baltzer","year":"2020","unstructured":"Baltzer P, Mann RM, Iima M, Sigmund EE, Clauser P, Gilbert FJ, et al. Diffusion-weighted imaging of the breast-a consensus and mission statement from the EUSOBI International Breast Diffusion-Weighted Imaging working group. Eur Radiol. 2020;30(3):1436\u201350. https:\/\/doi.org\/10.1007\/s00330-019-06510-3.","journal-title":"Eur Radiol"},{"issue":"5","key":"1981_CR21","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1007\/s00330-016-4564-3","volume":"27","author":"H Bickel","year":"2017","unstructured":"Bickel H, Pinker K, Polanec S, Magometschnigg H, Wengert G, Spick C, et al. Diffusion-weighted imaging of breast lesions: region-of-interest placement and different ADC parameters influence apparent diffusion coefficient values. Eur Radiol. 2017;27(5):1883\u201392.","journal-title":"Eur Radiol"},{"issue":"1","key":"1981_CR22","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ejrad.2015.10.018","volume":"85","author":"F Kato","year":"2016","unstructured":"Kato F, Kudo K, Yamashita H, Wang J, Hosoda M, Hatanaka KC, et al. Differences in morphological features and minimum apparent diffusion coefficient values among breast cancer subtypes using 3-tesla MRI. Eur J Radiol. 2016;85(1):96\u2013102. https:\/\/doi.org\/10.1016\/j.ejrad.2015.10.018.","journal-title":"Eur J Radiol"},{"issue":"3","key":"1981_CR23","doi-asserted-by":"publisher","first-page":"717","DOI":"10.2214\/AJR.11.7093","volume":"198","author":"M Hirano","year":"2012","unstructured":"Hirano M, Satake H, Ishigaki S, Ikeda M, Kawai H, Naganawa S. Diffusion-weighted imaging of breast masses: comparison of diagnostic performance using various apparent diffusion coefficient parameters. AJR Am J Roentgenol. 2012;198(3):717\u201322. https:\/\/doi.org\/10.2214\/AJR.11.7093.","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"1981_CR24","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1002\/jmri.28600","volume":"58","author":"Y Li","year":"2023","unstructured":"Li Y, Chen J, Yang Z, Fan C, Qin Y, Tang C, et al. Contrasts between diffusion-weighted imaging and dynamic contrast-enhanced MR in diagnosing malignancies of breast nonmass enhancement lesions based on morphologic assessment. J Magn Reson Imaging. 2023;58(3):963\u201374. https:\/\/doi.org\/10.1002\/jmri.28600.","journal-title":"J Magn Reson Imaging"},{"issue":"6","key":"1981_CR25","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.2214\/AJR.09.3534","volume":"194","author":"SC Partridge","year":"2010","unstructured":"Partridge SC, Mullins CD, Kurland BF, Allain MD, DeMartini WB, Eby PR, et al. Apparent diffusion coefficient values for discriminating benign and malignant breast MRI lesions: effects of lesion type and size. AJR Am J Roentgenol. 2010;194(6):1664\u201373. https:\/\/doi.org\/10.2214\/AJR.09.3534.","journal-title":"AJR Am J Roentgenol"},{"issue":"9","key":"1981_CR26","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1007\/s00330-011-2140-4","volume":"21","author":"H Rahbar","year":"2011","unstructured":"Rahbar H, Partridge SC, Eby PR, Demartini WB, Gutierrez RL, Peacock S, et al. Characterization of ductal carcinoma in situ on diffusion weighted breast MRI. Eur Radiol. 2011;21(9):2011\u20139. https:\/\/doi.org\/10.1007\/s00330-011-2140-4.","journal-title":"Eur Radiol"},{"issue":"8","key":"1981_CR27","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.mri.2015.06.002","volume":"33","author":"M Telegrafo","year":"2015","unstructured":"Telegrafo M, Rella L, Stabile Ianora AA, Angelelli G, Moschetta M. Unenhanced breast MRI (STIR, T2-weighted TSE, DWIBS): an accurate and alternative strategy for detecting and differentiating breast lesions. Magn Reson Imaging. 2015;33(8):951\u20135. https:\/\/doi.org\/10.1016\/j.mri.2015.06.002.","journal-title":"Magn Reson Imaging"},{"issue":"1","key":"1981_CR28","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s10549-019-05519-y","volume":"180","author":"A Rotili","year":"2020","unstructured":"Rotili A, Trimboli RM, Penco S, Pesapane F, Tantrige P, Cassano E, et al. Double reading of diffusion-weighted magnetic resonance imaging for breast cancer detection. Breast Cancer Res Treat. 2020;180(1):111\u201320. https:\/\/doi.org\/10.1007\/s10549-019-05519-y.","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"1981_CR29","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.crad.2015.11.006","volume":"71","author":"CW Wan","year":"2016","unstructured":"Wan CW, Lee CY, Lui CY, Fong CY, Lau KC. Apparent diffusion coefficient in differentiation between malignant and benign breast masses: does size matter? Clin Radiol. 2016;71(2):170\u20137. https:\/\/doi.org\/10.1016\/j.crad.2015.11.006.","journal-title":"Clin Radiol"},{"key":"1981_CR30","volume-title":"ACR BI-RADS v2025 manual","author":"WB DeMartini","year":"2025","unstructured":"DeMartini WB, Strigel RM, Pinker K, Rahbar H, Wang LC. Magnetic resonance imaging. In: ACR BI-RADS v2025 manual. Reston: American College of Radiology; 2025."},{"issue":"1","key":"1981_CR31","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s11604-020-01029-w","volume":"39","author":"M Honda","year":"2021","unstructured":"Honda M, Kataoka M, Kawaguchi K, Iima M, Miyake KK, Kishimoto AO, et al. Subcategory classifications of breast imaging and data system (BI-RADS) category 4 lesions on MRI. Jpn J Radiol. 2021;39(1):56\u201365. https:\/\/doi.org\/10.1007\/s11604-020-01029-w.","journal-title":"Jpn J Radiol"},{"issue":"3","key":"1981_CR32","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1007\/s11604-017-0717-9","volume":"36","author":"T Asada","year":"2018","unstructured":"Asada T, Yamada T, Kanemaki Y, Fujiwara K, Okamoto S, Nakajima Y. Grading system to categorize breast MRI using BI-RADS 5th edition: a statistical study of non-mass enhancement descriptors in terms of probability of malignancy. Jpn J Radiol. 2018;36(3):200\u20138. https:\/\/doi.org\/10.1007\/s11604-017-0717-9.","journal-title":"Jpn J Radiol"},{"issue":"1","key":"1981_CR33","doi-asserted-by":"publisher","first-page":"222","DOI":"10.2214\/AJR.14.13834","volume":"205","author":"M de Almeida","year":"2015","unstructured":"de Almeida M, Gomes AB, Barros TP, Fahel PE, de Seixas Rocha M. Subcategorization of suspicious breast lesions (BI-RADS category 4) according to MRI criteria: role of dynamic contrast-enhanced and diffusion-weighted imaging. Am J Roentgenol. 2015;205(1):222\u201331. https:\/\/doi.org\/10.2214\/AJR.14.13834.","journal-title":"Am J Roentgenol"},{"key":"1981_CR34","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.12659\/msm.907000","volume":"24","author":"D Liu","year":"2018","unstructured":"Liu D, Ba Z, Ni X, Wang L, Yu D, Ma X. Apparent diffusion coefficient to subdivide breast imaging reporting and data system magnetic resonance imaging (BI-RADS-MRI) category 4 lesions. Med Sci Monit. 2018;24:2180\u20138. https:\/\/doi.org\/10.12659\/msm.907000.","journal-title":"Med Sci Monit"},{"issue":"3","key":"1981_CR35","doi-asserted-by":"publisher","first-page":"W118","DOI":"10.2214\/AJR.17.17926","volume":"210","author":"K Fujiwara","year":"2018","unstructured":"Fujiwara K, Yamada T, Kanemaki Y, Okamoto S, Kojima Y, Tsugawa K, et al. Grading system to categorize breast MRI in BI-RADS 5th edition: a multivariate study of breast mass descriptors in terms of probability of malignancy. AJR Am J Roentgenol. 2018;210(3):W118\u201327. https:\/\/doi.org\/10.2214\/AJR.17.17926.","journal-title":"AJR Am J Roentgenol"}],"container-title":["Japanese Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11604-026-01981-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11604-026-01981-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11604-026-01981-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T04:08:58Z","timestamp":1784866138000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11604-026-01981-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["1981"],"URL":"https:\/\/doi.org\/10.1007\/s11604-026-01981-z","relation":{},"ISSN":["1867-1071","1867-108X"],"issn-type":[{"value":"1867-1071","type":"print"},{"value":"1867-108X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,10]]},"assertion":[{"value":"7 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Mariko Goto received speaker honoraria from Bayer Yakuhin Ltd., Guerbet Japan Co.,Ltd. and GE Healthcare Pharma K.K., as well as travel and lodging support from Bayer Yakuhin Ltd., and has served on an advisory board for Bayer Yakuhin Ltd.. Mariko Goto serves as a councilor and Guideline Committee Member of the Japanese Breast Cancer Society and as an editorial board member of the Japanese Journal of Radiology; these roles are unpaid. Koji Sakai serves as an associate professor of a joint research laboratory supported by Doctor-NET Inc. Kei Yamada received research funding from Guerbet Japan, Doctor-NET Inc., and Fukushima SiC Applied Engineering Inc., speaker honoraria from Bracco Japan and Japan Medical Association, and payment for expert testimony. Kei Yamada serves as president of the Japanese College of Radiology and as secretary general of the Asian-Oceania Society of Neuroradiology and Head & Neck Radiology; these roles are unpaid. Saeko Usui, Toshiyuki Okamoto, and Yuka Onishi have no conflicts of interest to declare.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval was obtained from the institutional ethics committee of Kyoto Prefectural University of Medicine (No.: ERB-C-3260).","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The requirement for informed consent was waived because of the retrospective study design.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}